Yahoo
Tel Aviv - Delayed Quote ILA

SofWave Medical Ltd. (SOFW.TA)

3,739.00 -53.00 (-1.40%)
As of 3:34:22 PM GMT+3. Market Open.
Chart Range Bar
Loading chart for SOFW.TA
  • Previous Close 3,792.00
  • Open 3,792.00
  • Bid 3,713.00 x --
  • Ask 3,744.00 x --
  • Day's Range 3,612.00 - 3,790.00
  • 52 Week Range 2,417.00 - 4,869.00
  • Volume 27,246
  • Avg. Volume 67,399
  • Market Cap (intraday) 1.357B
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 63.37
  • EPS (TTM) 0.59
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.

sofwave.com

151

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .

YTD Return

SOFW.TA
35.96%
TA-125 (^TA125.TA)
11.66%

1-Year Return

SOFW.TA
42.76%
TA-125 (^TA125.TA)
31.72%

3-Year Return

SOFW.TA
0.00%
TA-125 (^TA125.TA)
0.00%

5-Year Return

SOFW.TA
39.83%
TA-125 (^TA125.TA)
123.34%

Earnings Trends

View More

Earnings Per Share (GAAP)

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    1.35B

  • Enterprise Value

    1.25B

  • Trailing P/E

    62.42

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.39

  • Price/Book (mrq)

    12.95

  • Enterprise Value/Revenue

    4.40

  • Enterprise Value/EBITDA

    40.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.48%

  • Return on Assets (ttm)

    11.83%

  • Return on Equity (ttm)

    27.43%

  • Revenue (ttm)

    104.34M

  • Net Income Avi to Common (ttm)

    8.85M

  • Diluted EPS (ttm)

    0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38.31M

  • Total Debt/Equity (mrq)

    3.75%

  • Levered Free Cash Flow (ttm)

    12.95M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: